LIMNW

Conviction 0HealthcareScan · Mon, Aug 10, 2026

LIMNW$0.0000-100.00%

ResistanceSupportVol 14

Vol MA14 1.33K

May 8May 27Jun 15Jul 2Jul 22Aug 7

Liminatus Pharma, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)liminatuspharma.com ↗

Price0.0000

Change-100.00%

Gap-100.00%

Rel volume0.02×

Avg volume2.21K

Avg $ vol126.31

SMA 200.0313

SMA 500.0310

SMA 2000.0399

Price vs 50-100.00%

Price vs 200-100.00%

MA stackbearish

50/200 cross—

Supertrendup · -0.0172

RSI (14)46

MACD hist-0.00

MACD crossbear · 8d

Stoch %K / %D0 / 26

ADX (14)8

+DI / −DI47 / 48

RSI divergence—

MACD divergence—

ATR %—

ADR %20.35%

52w high0.2350

52w low0.0000

From 52w high-100.00%

Above 52w low—

New 52w highNo

SqueezeOff

Bollinger width379.16%

%B0.24

Donchian pos0.00%

Donchian high0.0839

Donchian low0.0000

AVWAP (52w high)0.1016

vs AVWAP high-100.00%

AVWAP (52w low)0.1000

vs AVWAP low-100.00%

OBV trendFlat

Chaikin MF (20)-0.50

Today vs 20d0.02×

Avg vol (14d)1.33K

Avg vol (20d)2.21K

Avg $ vol (20d)126.31

Market cap0

RS 3m (vs SPY)-105.70%

RS 6m (vs SPY)-114.11%

RS line new highNo

Trend template0/8

Technical rank—

1 week—

1 month—

3 months-100.00%

6 months-100.00%

1 year-100.00%

YTD-100.00%

P/E0.00

P/B0.00

P/S—

P/FCF0.00

EPS-0.4300

Div yield—

ROE—

ROA-365.79%

Debt/Eq-10.88

Current0.96

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-187.81%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value1.44M

Revenue—

Net income-1.12M

Gross profit—

Free cash flow-9.98M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out7.74M

Employees1

ListedThu, May 1, 2025

Free float—

Float %—

Short interest3.51K

Days to cover1.1d

Short volume100.0%

Squeeze score42 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction0 / 100

Pattern quality—

Tech rank—

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance0.0957

Support0.0000

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in LIMNW

All disclosures →

No recent disclosed trades by Congress in LIMNW. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in LIMNW

No recent insider (Form 4) filings in LIMNW. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in LIMNW

EDGAR →

No recent SEC filings on file for LIMNW.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.